Required for Chronic Multi-morbidity & Outcomes Based Reimbursement (OBR)
Required for Chronic Multi-morbidity & Outcomes Based Reimbursement (OBR)
They are stuck in decades-old episodic, disease-centered, transactional infrastructure - in the U.S. and globally
By 2027, this gap will become a balance-sheet liability for every risk-bearing organization.
A category-defining Initial Product Release built through $5M Ez Bala's Founder-funded corporate venturing R&D at Alphind healthcare
Zypher.life closes that gap with a simple, defensible per-condition Whole Person Health Score-of-Scores, a GenAI generated SOAP-aligned Assessment and Plan, and Agentic One-Click Activation of physician-approved Plan-of-Care inside existing workflows.
Buyers describe a “negative-click” system that reduces cognitive load and workflow burden while building patient loyalty, reducing leakage, and - in their words - gives “an immediate way to grasp the overall health of the patient and the best path forward.”
The product is built, the IP is owned, and the demand is validated.
No incumbent - EHR, data warehouse, AI assistant, or wellness ring composes a single, per-condition whole-person health score-of-scores of individuals and their lookalike populations.
Demand is not being manufactured: the worldwide search for “Whole Person Care” has grown roughly 5× over the past decade, concentrated in exactly Zypher’s go-to-market geographies, as federal policy institutionalizes the term and clinicians shift to AI at the point of care.
Its anchor adjacency, Population Health Management, is forecast to grow from $85B to $281B by 2030 (22% CAGR).
The international tail is larger still: 2.5B adults with ≥2 conditions, 860M with ≥4, and 400M with ≥6 by 2030.
They need it. They want it. They have nothing like it.
Form NewCo and recruit world class executive leadership team to 'hit-the-ground-running' on Day One.
Clean IP transfer from Alphind healthcare developed through a five-year, $5M corporate venturing R&D funded by Ez Bala, Investor & Co-Founder of Zypher.life.
Convert Voice-of-Customer signal into ≥2 paid early-adopter contracts or binding LOIs, and accelerate the platform's scope and path to MVP and Minimum Viable Repeatability (MVR).
Join us and discover what we can do for you.
The content throughout this website is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities. Forward-looking statements (including projections, trends, and business plans) involve risks and uncertainties, and actual results may differ materially from those expressed or implied. This site contains intellectual property of Alphind healthcare and of R&D Ribitzky © 2026. All rights reserved. Other brands and names are the property of their respective owners.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.